Logo

Caprotec Bioanalytics

String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms
Premium

While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.

Caprotec Signs Plant Proteomics Research Deal with Syngenta

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research agreement with Syngenta to profile the interactions of one of Syngenta's active compounds with the proteome of certain relevant plant systems.

Caprotec Enters Second Collaboration with Bayer CropScience for Use of CCMS Technology

NEW YORK (GenomeWeb News) – Berlin-based biotech-firm Caprotec Bioanalytics said today that it has entered a research collaboration with Bayer CropScience to identify and study an agrochemical target.

People in the News: BG Medicine, Caprotec, and More
Premium

BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO.

Caprotec, Bayer CropScience Reach Screening Deal

NEW YORK (GenomeWeb News) – Caprotec Bioanalytics has reached an agreement to use its technology to screen an undisclosed new active ingredient from Bayer CropScience.